NO20034414L - Anvendelse av N-fenyl-2-pyrimidinaminderivater mot mastcellebaserte sykdommer slik som allergiske forstyrrelser - Google Patents

Anvendelse av N-fenyl-2-pyrimidinaminderivater mot mastcellebaserte sykdommer slik som allergiske forstyrrelser

Info

Publication number
NO20034414L
NO20034414L NO20034414A NO20034414A NO20034414L NO 20034414 L NO20034414 L NO 20034414L NO 20034414 A NO20034414 A NO 20034414A NO 20034414 A NO20034414 A NO 20034414A NO 20034414 L NO20034414 L NO 20034414L
Authority
NO
Norway
Prior art keywords
phenyl
mast cell
allergic disorders
based diseases
derivatives against
Prior art date
Application number
NO20034414A
Other languages
English (en)
Other versions
NO20034414D0 (no
NO325454B1 (no
Inventor
Kenichi Koike
Atsushi Komiyama
Kovichi Takeuchi
Original Assignee
Us Gov Veterans Affairs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Veterans Affairs filed Critical Us Gov Veterans Affairs
Publication of NO20034414D0 publication Critical patent/NO20034414D0/no
Publication of NO20034414L publication Critical patent/NO20034414L/no
Publication of NO325454B1 publication Critical patent/NO325454B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO20034414A 2001-04-05 2003-10-02 Anvendelse av N-{5-[4-(4-metyl-piperazino-metyl)-benzoylamido]-2-metylfenyl}-4-(3-pyridyl)-2-pyrimidin-amin. NO325454B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0108606.5A GB0108606D0 (en) 2001-04-05 2001-04-05 Organic compounds
PCT/US2002/010742 WO2002080925A1 (en) 2001-04-05 2002-04-05 Use of n-phenyl-2-pyrimidineamine derivativea against mast cell-based diseases like allergic disorders

Publications (3)

Publication Number Publication Date
NO20034414D0 NO20034414D0 (no) 2003-10-02
NO20034414L true NO20034414L (no) 2003-12-04
NO325454B1 NO325454B1 (no) 2008-05-05

Family

ID=9912339

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034414A NO325454B1 (no) 2001-04-05 2003-10-02 Anvendelse av N-{5-[4-(4-metyl-piperazino-metyl)-benzoylamido]-2-metylfenyl}-4-(3-pyridyl)-2-pyrimidin-amin.

Country Status (18)

Country Link
EP (1) EP1389113A1 (no)
KR (2) KR20090034998A (no)
CN (1) CN1529602A (no)
AU (1) AU2002307140B2 (no)
BR (1) BR0208663A (no)
CA (1) CA2443092A1 (no)
CZ (1) CZ20032705A3 (no)
GB (1) GB0108606D0 (no)
HU (1) HUP0303751A3 (no)
IL (1) IL158061A0 (no)
MX (1) MXPA03009058A (no)
NO (1) NO325454B1 (no)
NZ (1) NZ528934A (no)
PL (1) PL363080A1 (no)
RU (1) RU2304436C2 (no)
SK (1) SK12312003A3 (no)
WO (1) WO2002080925A1 (no)
ZA (1) ZA200307563B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003003006A2 (en) 2001-06-29 2003-01-09 Ab Science New potent, selective and non toxic c-kit inhibitors
ATE330608T1 (de) 2001-06-29 2006-07-15 Ab Science Die verwendung von n-phenyl-2-pyrimidine-amine derivaten zur behandlung von entzündlichen erkrankungen
PT1401416E (pt) 2001-06-29 2007-02-28 Ab Science Utilização de inibidores de c-kit para tratar doenças inflamatórias intestinais (dii)
ES2274993T3 (es) 2001-06-29 2007-06-01 Ab Science Utilizacion de inhibidores de tirosina cinasa para el tratamiento de enfermedades alergicas.
GB0201882D0 (en) * 2002-01-28 2002-03-13 Novartis Ag Organic compounds
CA2479257A1 (en) * 2002-03-21 2003-10-02 Dana-Farber Cancer Institute, Inc. Inhibition of cell death responses induced by oxidative stress
MXPA05001277A (es) 2002-08-02 2005-10-06 Ab Science 2-(3-aminoaril)amino-4-aril-tiazoles y su uso como inhibidores del c-kit.
US8450302B2 (en) 2002-08-02 2013-05-28 Ab Science 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
GB2398565A (en) * 2003-02-18 2004-08-25 Cipla Ltd Imatinib preparation and salts
ATE393243T1 (de) * 2003-02-27 2008-05-15 Ab Science Diagnostisches verfahren der mastozytose
AU2003232650A1 (en) * 2003-05-06 2004-11-26 Il Yang Pharm Co., Ltd. N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
TWI324604B (en) * 2003-06-18 2010-05-11 Novartis Ag New use of staurosporine derivatives
WO2005115385A1 (en) * 2004-05-24 2005-12-08 Ab Science Use of c-kit inhibitors for treating acne
CA2578122A1 (en) * 2004-08-27 2006-03-02 Gpc Biotech Ag Pyrimidine derivatives
CN103638028A (zh) * 2005-05-02 2014-03-19 诺瓦提斯公司 嘧啶基氨基苯甲酰胺衍生物用于治疗全身性肥大细胞增多症的应用
KR100845278B1 (ko) * 2006-08-04 2008-07-09 포항공과대학교 산학협력단 비만 세포의 활성을 유도하는 펩타이드 및 이를 포함하는면역조절제
EP2417972B1 (en) * 2009-04-06 2017-06-14 Neurotech Pharmaceuticals Co., Ltd. Pharmaceutical composition for treating or preventing burn injuries
CN103058935B (zh) * 2013-01-15 2015-05-06 四川大学 一种嘧啶类化合物及其制备方法和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4940418A1 (es) * 1997-07-18 2000-07-24 Novartis Ag Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso

Also Published As

Publication number Publication date
IL158061A0 (en) 2004-03-28
AU2002307140B2 (en) 2006-02-16
NZ528934A (en) 2006-10-27
ZA200307563B (en) 2004-04-21
HUP0303751A2 (hu) 2005-04-28
CN1529602A (zh) 2004-09-15
GB0108606D0 (en) 2001-05-23
WO2002080925A1 (en) 2002-10-17
CA2443092A1 (en) 2002-10-17
NO20034414D0 (no) 2003-10-02
RU2003130635A (ru) 2005-02-10
SK12312003A3 (sk) 2004-02-03
RU2304436C2 (ru) 2007-08-20
MXPA03009058A (es) 2004-11-22
KR20090034998A (ko) 2009-04-08
BR0208663A (pt) 2004-03-09
CZ20032705A3 (en) 2004-06-16
NO325454B1 (no) 2008-05-05
HUP0303751A3 (en) 2005-06-28
KR20040007485A (ko) 2004-01-24
EP1389113A1 (en) 2004-02-18
PL363080A1 (en) 2004-11-15

Similar Documents

Publication Publication Date Title
NO20034414D0 (no) Anvendelse av N-fenyl-2-pyrimidinaminderivater mot mastcellebaserte sykdommer slik som allergiske forstyrrelser
NO20043158L (no) Substituerte kinazolinderivater som inhibitorer av aurorakinaser
NO20042842L (no) Farmasoytiske formuleringer av platina-derivat
NO20034523L (no) Pyrazolderivater for behandling av HIV
NO20035193L (no) Nye pyrrolderivater som farmas degree ytiske midler
EE200300359A (et) Asendatud asaindooloksoatseetpiperasiini derivaatide koostis ja viirusevastane toime
NO20041386L (no) Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser
NO20033594D0 (no) Fenetanolamin-derivater for behandling av luftveissykdommer
NO20042112L (no) Anvendelse av glycosider av mono- og diacylglycerol som anti-inflammatoriske midler.
CY2017048I1 (el) Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης
ATE353627T1 (de) Stabilisierte orale suspensionsformulierung
DE50202479D1 (de) Saure pigmentdispergatoren und pigmentzubereitungen
EP1585519A4 (en) HIGH CONCENTRATION OPIOID FORMULATIONS AND OPIOID DERIVATIVES
DK1387838T3 (da) Cyanoanthranylamid-derivater og deres anvendelse som lægemidler
NO20041968L (no) Anvendelse av cystationin
AU2003278157A1 (en) Novel phenylethanolamine derivatives and the use of the same as beta-3-agonists
DK1475379T3 (da) Anvendelse af scopinesterderivater til fremstilling af lægemidler
AU2003209647A1 (en) Optical measurements of patterned structures
NO20043084L (no) 3-fenyl-2-arylalkyltiopropionsyre derivater som selektive agnoister av PPAR-ALPHA
EE200300570A (et) Imidasotriasinoonide derivaadid ja nende kasutamine põletikuliste protsesside ja/või immuunhaigustevastu
PT1392670E (pt) Derivados substituidos de c-furan-2-il-metilamina e c-tiofen-2-il-metilamina
NO20015033D0 (no) Anvendelse av maduraftalazinderivater som inhibitorer av proinflammatoriske cytokiner
DK1373249T3 (da) Imidazolidinderivater, deres fremstilling og deres anvendelse som anti-inflammatorisk middel
PT1385512E (pt) Utilizacao de derivados de piridoindolona para preparacao de medicamentos anticancerigenos
HK1062890A (en) Use of n-phenyl-2-pyrimidineamine derivatives against mast cell-based diseases like allergic disorders

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees